Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET). Universidad de Buenos Aires. Facultad de Psicología, Buenos Aires, Argentina.
Medicina Reproductiva Fertilis, Laboratorio de Biología de la Reproducción, Boulogne, Buenos Aires, Argentina.
JBRA Assist Reprod. 2021 Feb 2;25(1):150-154. doi: 10.5935/1518-0557.20200038.
CRISPR/Cas9 can be considered as the biotechnological breakthrough of the century. Genome editing technologies have developed in a vertiginous way. While the genome editing of species, including animals, plants and bacteria has become a commonly used method, the application of CRISPR-Cas9 in human embryos has led to debates and interdisciplinary discussions. This brings multiple challenges for both scientists and those who must regulate the use of these techniques.
CRISPR/Cas9 可以被视为本世纪的生物技术突破。基因组编辑技术发展迅速。虽然包括动物、植物和细菌在内的物种的基因组编辑已经成为一种常用的方法,但 CRISPR-Cas9 在人类胚胎中的应用引发了争论和跨学科讨论。这给科学家和那些必须监管这些技术使用的人带来了多重挑战。